TOFACITINIB INDUCES CLINICAL AND ENDOSCOPIC REMISSION IN BIOLOGIC REFRACTORY ULCERATIVE COLITIS PATIENTS: A REAL-WORLD BELGIUM COHORT STUDY

被引：0
|
作者：
Cremer, Anneline
Lobaton, Triana
Vieujean, Sophie
Bossuyt, Peter
Rahier, Jean-Francois
Baert, Filip J.
Dewit, Olivier
Macken, Elisabeth
Somers, Michael
Vijverman, Anne
Van Hootegem, Philippe
Mana, Fazia
Willandt, Barbara
Caenepeel, Philip
Humblet, Evelien
D'Heygere, Francois
Verreth, Annelies
El Nawar, Abdo
Coenegrachts, Jean-Louis
Dewit, Sophie
De Coninck, Steven
Schoofs, Nele
Delen, Stefan
Dutre, Joris
Thienpont, Clara
Vanden Branden, Stijn
Staessen, Dirk
Franchimont, Denis
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1895
引用
收藏
页码：S1208 / S1208
页数：1
相关论文
共 50 条
  • [1] eTofacitinib induces clinical and endoscopic remission in biologic refractory ulcerative colitis patients: a real-world Belgian cohort study
    Cremer, A.
    Lobaton, T.
    Vieujan, S.
    Bossuyt, P.
    Rahier, J. F.
    Baert, F.
    Dewit, O.
    Somers, M.
    Macken, E.
    Vijverman, A.
    Van Hootegem, P.
    Mana, F.
    Willandt, B.
    Caenepeel, P.
    Humblet, E.
    D'Heygere, F.
    Verreth, A.
    El Nawar, A.
    Coenegrachts, J. L.
    Dewit, S.
    De Coninck, S.
    Schoofs, N.
    Delen, S.
    Dutre, J.
    Thienpont, C.
    Vanden Branden, S.
    Staessen, D.
    Franchimont, D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S384 - S386
  • [2] Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis
    Deepak, Parakkal
    Alayo, Quazim A.
    Khatiwada, Aava
    Lin, Bixuan
    Fenster, Marc
    Dimopoulos, Christina
    Bader, Geoffrey
    Weisshof, Roni
    Jacobs, Michael
    Gutierrez, Alexandra
    Ciorba, Matthew A.
    Christophi, George P.
    Patel, Anish
    Hirten, Robert P.
    Colombel, Jean-Frederic
    Rubin, David T.
    Ha, Christina
    Beniwal-Patel, Poonam
    Ungaro, Ryan C.
    Syal, Gaurav
    Pekow, Joel
    Cohen, Benjamin L.
    Yarur, Andres
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (08) : 1592 - +
  • [3] Real-world tofacitinib effectiveness and safety in patients with refractory ulcerative colitis
    Lair-Mehiri, L.
    Stefanescu, C.
    Vaysse, T.
    Laharie, D.
    Roblin, X.
    Rosa, I.
    Treton, X.
    Abitbol, V.
    Amiot, A.
    Bouguen, G.
    Dib, N.
    Fumery, M.
    Pariente, B.
    Carbonnel, F.
    Peryn-Biroulet, L.
    Simon, M.
    Viennot, S.
    Bouhnik, Y.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S478 - S479
  • [4] REAL-WORLD EXPERIENCE OF USING TOFACITINIB IN ULCERATIVE COLITIS IN BIOLOGIC NAIVE AND BIOLOGIC EXPOSED PATIENTS
    Cheesbrough, Jonathan
    Sharma, Naveen
    Nassar, Islam
    Quraishi, Nabil
    GUT, 2022, 71 : A42 - A42
  • [5] Real-world experience of using Tofacitinib in Ulcerative Colitis in biologic naive and biologic exposed patients
    Cheesbrough, J.
    Quraishi, M. N.
    Sharma, N.
    Nassar, I.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I443 - I444
  • [6] Real-world experience of using Tofacitinib in Ulcerative Colitis in biologic naive and biologic exposed patients
    Cheesbrough, J.
    Quraishi, M. N.
    Sharma, N.
    Nassar, I.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I443 - I444
  • [7] Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis
    Lair-Mehiri, Loriane
    Stefanescu, Carmen
    Vaysse, Thibaut
    Laharie, David
    Roblin, Xavier
    Rosa, Isabelle
    Treton, Xavier
    Abitbol, Vered
    Amiot, Aurelien
    Bouguen, Guillaume
    Dib, Nina
    Fumery, Mathurin
    Pariente, Benjamin
    Carbonnel, Franck
    Peyrin-Biroulet, Laurent
    Simon, Marion
    Viennot, Stephanie
    Bouhnik, Yoram
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (03) : 268 - 273
  • [8] Ustekinumab induces clinical and biological remission in biologic refractory Crohn's disease patients: A real-world belgian cohort study
    Liefferinckx, C.
    Verstockt, B.
    Gils, A.
    Noman, M.
    Van Kemseke, C.
    Macken, E.
    De Vos, M.
    Van Moerkercke, W.
    Rahier, J. -F.
    Bossuyt, P.
    Dutre, J.
    Humblet, E.
    Staessen, D.
    Peeters, H.
    Van Hootegem, P.
    Louis, E.
    Franchimont, D.
    Baert, F.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S31 - S32
  • [9] TREATMENT PERSISTENCE RATES WITH TOFACITINIB IN A REAL-WORLD COHORT OF ANTI-TNF REFRACTORY ULCERATIVE COLITIS PATIENTS
    Conley, Thomas
    Colclough, James
    Liu, Eleanor
    Razanskaite, Violeta
    Jakobek, William
    Limdi, Jimmy
    Flanagan, Paul
    Subramanian, Sreedhar
    GUT, 2021, 70 : A88 - A89
  • [10] CLINICAL CHARACTERISTICS AND HEALTHCARE RESOURCE UTILIZATION IN A REAL-WORLD COHORT OF PATIENTS WITH ULCERATIVE COLITIS TREATED WITH TOFACITINIB
    Chiorean, Michael V.
    Sharma, Puza P.
    Salese, Leonardo
    Gruben, David
    Woolcott, John
    Khan, Nabeel
    GASTROENTEROLOGY, 2021, 160 (06) : S229 - S230
12345